Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin

Molecular Carcinogenesis

Volumn 35, Issue 4, 2002, Pages 173-179

  Takeuchi, Tamotsu ^a   Liang, Sheng Ben ^b   Ohtsuki, Yuji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Basal cell carcinoma; CDH13; H cadherin; Loss of heterozygosity; Methylation; Skin; T cadherin

Indexed keywords

CADHERIN; T CADHERIN; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; CLINICAL ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; METASTASIS; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; SKIN CARCINOMA; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CADHERINS; CARCINOMA, BASAL CELL; DNA PRIMERS; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; SKIN NEOPLASMS;

EID: 0036924686     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10088     Document Type: Article

References (25)

1. Takeuchi T, Liang SB, Matsuyoshi N, et al. Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest 2002;82:1023-1029.
2. Zhou S, Matsuyoshi N, Liang SB, Takeuchi T, Ohtsuki Y, Miyachi Y. Expression of T-cadherin in basal keratinocytes of skin. J Invest Dermatol 2002;118:1080-1084.
3. Krüger K, Blume-Peytavi U, Orfanos CE. Basal cell carcinoma possibly originates from the outer root sheath and/or bulge region of the vellus hair follicle. Arch Dermatol Res 1999;291:253-259.
4. Ranscht B, Dours-Zimmermann MT. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system, lacks the conserved cytoplasmic region. Neuron 1991;7:391-402.
5. Takeuchi T, Ohtsuki Y. Recent progress of T-cadherin (CDH13, H-cadherin) research. Histol Histopathol 2001;16: 1287-1293.
6. Lee SW. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 1996;2:776-782.
7. Sato M, Mori Y, Sakurada A, Fujimura S, Horii A. The H-cadherin (CDH13) gene is inactivated in human lung cancer. [Published erratum in Hum Genet 1998;103:532.] Hum Genet 1998;103:96-101.
8. Toyooka KO, Toyooka S, Virmani AK, etal. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 2001;61:4556-4560.
9. Kawakami M, Staub J, Cliby W, Hartmann L, Smith DI, Shridhar V. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol 1999;15:715-720.
10. Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 2001; 61:8659-8663.
11. Lee SW, Reimer CL, Campbell DB, Cheresh P, Duda RB, Kocher O. H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 1998;19: 1157-1159.
12. Takeuchi T, Misaki A, Chen BK, Ohtsuki Y. H-cadherin expression in breast cancer. Histopathology 1999;35:87-88.
13. Rippey JJ. Why classify basal cell carcinomas? Histopathology 1998;32:393-398.
14. Takeuchi T, Nicole S, Misaki A, et al. Expression of SMARCF1, a truncated form of SWI1, in neuroblastoma. Am J Pathol 2001;158:663-672.
15. Sato M, Mori Y, Sakurada A, Fujimura S, Horii A. A GT dinucleotide repeat polymorphism in intron 1 of the H-cadherin (CDH13) gene. J Hum Genet 1998;43:285-286.
16. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993;67:1262-1267.
17. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93: 9821-9826.
18. Fan X, Inda MM, Tunon T, Castresana JS. Improvement of the methylation specific PCR technical conditions for the detection of p16 promoter hypermethylation in small amounts of tumor DNA. Oncol Rep 2002;9:181-183.
19. Birchmeier W, Behrens J. Molecular mechanism leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol 1993;4:231-239.
20. Fuller LC, Allen MH, Montesu M, et al. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours. Br J Dermatol 1996;134:28-32.
21. Pizarro A, Gamallo C, Benito N, et al. Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours. Br J Cancer 1995;72:327-332.
22. Tada H, Hatoko M, Tanaka A, Kuwahara M, Muramatsu T. Expression of desmoglein I and plakoglobin in skin carcinomas. J Cutan Pathol 2000;27:24-29.
23. Lo JS, Snow SN, Reizner GT. Metastatic basal cell carcinoma: Report of twelve cases with a review of the literature. J Am Acad Dermatol 1991;24:715-719.
24. Miki Y, Katagiri T, Nakamura Y. Infrequent mutation of the H-cadherin gene on chromosome 16q24 in human breast cancers. Jpn J Cancer Res 1997;88:701-704.
25. Jhaveri M, Wagner C, Trepel JB. Impact of extracellular folate levels on global gene expression. Mol Pharmacol 2001;60: 1288-1295.